

Fast and reliable results with very high sensitivity.Validated specimen types: nasal, nasopharyngeal, oropharyngeal.Parallel discrimination between S gene wildtype and mutations N501Y, E484K, and K417N.The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime ® SARS-CoV-2 (COVID-19) RT-PCR kit. GSD NovaType IISARS-CoV-2 qPCR allows for the qualitative detection and discrimination of the SARS-CoV-2 S gene variants wildtype, and mutations K417N (specific to B.1.351, Beta), E484K and N501Y (common to most VOC). Internal positive control to monitor successful extraction and amplification of sample material GSD NovaType II.Specimen types: nasal, nasopharyngeal, oropharyngeal.Detection of N501Y and/or E484K mutations in the spike protein.
#Bead tool 4 completo plus
The CE-marked GSD NovaPrime ® Plus SARS-CoV-2 is a new Multiplex Real-Time RT-PCR assay intended for the qualitative detection of SARS-CoV-2 and the simultaneous discrimination of B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.1.248 (P.1) (Gamma) lineages in one reaction.

Real-Time RT-PCR Kits for Detection and Identification of Variants GSD NovaType Detect&Select SARS-CoV-2 NEW! The rapid emergence of new virus variants represents a continuous challenge and underlines the need to identify, trace and track mutations.

PCR allows for detection a few days after infection as well as in subclinical / asymptomatic infections. Eurofins Technologies teams have worked diligently in close collaboration with leading research hospitals and many of Eurofins human clinical testing laboratories around the world to develop a broad range of testing methods to support healthcare providers.ĭirect pathogen detection via PCR is the method of choice to detect acute COVID-19 infections. A comprehensive product portfolio is essential to support the tremendous efforts of health authorities working on SARS-CoV-2 detection and COVID-19 control globally.
